Skip to content

Ophthalmological Safety of Kajal

Evaluation of Ophthalmological safety of Test product Boddess INK D Kajal in healthy human female participants. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109420
Enrollment
24
Registered
2026-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Boddess INK D Kajal B No B42: Product will be applied Only Once on the right eye Control Intervention1: Nil: No product application on left eye

Sponsors

House of Beauty Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy female participants in the age group of 18 65 years both age inclusive Participants having Clinically normal eyes and periocular skin Participant with No history of ocular diseases Participant who is a Non contact lens Contact lens users Participant Willing to avoid other eye cosmetics products during the study period Participant is a frequent user of eye make up products Participants representing normal oily dry and combination skin type in nearly equal ratio Participants willing to give a voluntary written informed consent

Exclusion criteria

Exclusion criteria: Participants with known allergies or skin and or eye conditions which would interfere with the study Participant is Pregnant or Lactating Participant having any active eye condition redness infection or irritation Participant having any chronic ocular disorders or recent eye surgery Participant using any eye medications Participants participated in any other cosmetic or therapeutic trial or in a similar investigation

Design outcomes

Primary

MeasureTime frame
Ophthalmological SafetyTimepoint: Baseline Immediate post 2 hours post and 24 hours post application

Secondary

MeasureTime frame
NilTimepoint:

Countries

India

Contacts

Public ContactDr Amit Kumar Meena

Auriga Research Private Limited

amitgothwal15@gmail.com09799358378

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026